You are viewing the site in preview mode
Skip to main content
|
Malaria national intervention policy and strategy adoption
|
Factor 1
|
Factor 2
|
Factor 3
|
Factor 4
|
Factor 5
|
Factor 6
|
|---|
|
ITNs/LLINs are distributed free of charge
|
− 0.31
|
− 0.22
|
− 0.59
|
0.56
|
0.32
|
0.06
|
|
ITNs/LLINs are distributed to all age groups
|
0.03
|
0.58
|
− 0.11
|
0.66
|
0.01
|
− 0.40
|
|
ITNs/LLINs distributed through mass campaigns to all age groups
|
− 0.47
|
0.41
|
− 0.5
|
0.18
|
0.29
|
− 0.31
|
|
IRS is recommended by malaria control programme
|
− 0.16
|
0.68
|
0.11
|
− 0.47
|
0.19
|
− 0.34
|
|
DDT is used for IRS
|
− 0.03
|
0.57
|
0.47
|
− 0.04
|
0.61
|
0.25
|
|
IPTp is used to prevent malaria during pregnancy
|
− 0.66
|
0.05
|
0.6
|
0.38
|
− 0.15
|
0.06
|
|
Seasonal malaria chemoprevention (SMC or IPTc)
|
− 0.67
|
− 0.08
|
0.65
|
0.26
|
− 0.02
|
− 0.02
|
|
Patients of all ages should get diagnostic test
|
0.55
|
0.01
|
0.66
|
0.5
|
− 0.05
|
0.03
|
|
Malaria diagnosis is free of charge in the public sector
|
0.67
|
0.21
|
0.05
|
0.33
|
0.43
|
0.34
|
|
RDTs are used at community level
|
− 0.41
|
0.35
|
− 0.43
|
− 0.11
|
− 0.07
|
0.61
|
|
G6PD test is recommended before treatment with primaquine
|
0.40
|
0.25
|
− 0.31
|
0.49
|
− 0.54
|
0.11
|
|
ACT for treatment of Plasmodium falciparum
|
− 0.40
|
0.82
|
0.08
|
− 0.08
|
− 0.37
|
0.02
|
|
Pre-referral treatment with quinine or artemether IM or artesunate supp
|
− 0.70
|
0.32
|
− 0.19
|
0.15
|
− 0.12
|
0.21
|
|
Single dose of primaquine is used as gametocidal medicine for Plasmodium falciparum
|
0.68
|
0.53
|
− 0.01
|
− 0.05
|
0.02
|
0.1
|
|
Primaquine is used for radical treatment of Plasmodium vivax
|
0.91
|
0.01
|
− 0.17
|
0.11
|
0.05
|
− 0.13
|
|
Directly observed treatment with primaquine is undertaken
|
0.66
|
0.43
|
0.10
|
− 0.22
|
− 0.29
|
0.04
|
- Factor loadings: factors 1–6
